Telehealth General Psychiatry Prescribing: What Psychiatric NPs Can Do in North Carolina

If you’re a psychiatrist or psychiatric nurse practitioner, you’ve probably searched ‘can I prescribe [medication] via telehealth in [state]?’ at 11 PM while onboarding a new patient. Or maybe you’re trying to figure out if you need a collaborating physician, what controlled substances you can actually prescribe, and whether your state’s rules changed again last year.

You’re not alone. Prescribing in psychiatry—especially via telehealth—sits at the intersection of evolving federal rules, inconsistent state laws, and specialty-specific exceptions. Unlike cardiology or dermatology, psychiatry deals heavily with controlled substances (stimulants for ADHD, benzodiazepines for anxiety, buprenorphine for opioid use disorder), which means you’re navigating not just state scope-of-practice laws but also DEA regulations that are still in flux post-pandemic.

This guide cuts through the noise. We’ll cover what psychiatrists and PMHNPs can prescribe, how telehealth rules differ by state, what collaborative agreements actually require, and how reimbursement works when you’re managing medications remotely. If you’re practicing in California, Texas, Florida, New York, Pennsylvania, or Illinois—or thinking about expanding to those states—you’ll find state-specific breakdowns that go beyond ‘check your state board.’

Let’s start with the big question: what can you actually do as a prescriber in telepsychiatry right now?

What Psychiatrists Can Prescribe via Telehealth (and What’s Still Uncertain)

As a fully licensed psychiatrist (MD/DO), your prescribing authority is broad: you can prescribe any psychiatric medication—antidepressants, antipsychotics, mood stabilizers, stimulants, benzodiazepines, buprenorphine—across all 50 states, as long as you’re licensed in the state where the patient is located.

The Telehealth Part: Since March 2020, the DEA has waived the Ryan Haight Act’s in-person exam requirement for prescribing controlled substances via telemedicine. That waiver has been extended multiple times and remains in effect through December 31, 2025. This means you can legally start a new patient on Adderall or Xanax via video visit without ever seeing them in person, under federal law.

Here’s what that looks like in practice:

• Initial psychiatric evaluation (CPT 90792): You conduct a 60-minute video consult, diagnose ADHD, and prescribe methylphenidate (Schedule II). Completely legal under the current federal waiver.
• Follow-up med checks (CPT 99213/99214): You adjust doses, monitor side effects, and renew prescriptions—all via 15-20 minute telehealth visits.
• Buprenorphine for opioid use disorder: The X-waiver requirement was eliminated in 2023, so any DEA-registered practitioner can prescribe buprenorphine. You can initiate treatment via telehealth under the same waiver.

The Catch: The DEA has proposed new rules that could re-impose some in-person requirements after 2025—possibly requiring an initial in-person visit for new controlled substance patients, or limiting initial teleprescriptions to 30-day supplies. These rules aren’t finalized, and the DEA has repeatedly extended flexibility because access to psychiatric care would crater without it. Still, expect to hear more by late 2024 or early 2025.

State-Level Variations

Even with federal flexibility, some states add their own restrictions:

Florida explicitly permits controlled substance prescribing via telehealth for psychiatric treatment (Florida Statute 456.47). You can start ADHD meds or manage anxiety with benzodiazepines remotely for Florida patients—no state-level prohibition. However, Florida does ban teleprescribing controlled substances for chronic pain management (that still requires in-person).

Texas allows telemedicine prescribing if the standard of care is met, but prohibits prescribing Schedule II opioids for chronic pain via telehealth. Psychiatric treatment is fine—so you can prescribe stimulants for ADHD via video—but pain management is off-limits. Texas also requires you to check the state’s Prescription Monitoring Program (PMP) before prescribing any controlled substance.

New York finalized regulations in mid-2025 that align state law with federal telehealth allowances. You can prescribe controlled substances via telehealth as long as federal law (the DEA waiver) permits it. New York previously required an in-person exam, but that rule now defers to federal flexibility.

California has no state-level ban on controlled substance teleprescribing. California law requires a ‘good faith exam’ before prescribing, but telehealth evaluations count. You must enroll in California’s CURES (PMP) system and check it at least once every four months for patients on ongoing Schedule II-IV therapy.

Pennsylvania and Illinois defer to federal law—no additional state restrictions on controlled substance teleprescribing during the waiver period. Both require PMP checks.

The Bottom Line for Psychiatrists: You have near-universal ability to prescribe psychiatric medications via telehealth in 2026, including controlled substances for ADHD, anxiety, and substance use disorders. Stay current on DEA announcements (follow the DEA Diversion Control website or professional associations like the APA), and be prepared to adapt if rules tighten post-2025.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

PMHNP vs. Psychiatrist: How Prescribing Authority Actually Differs by State

Here’s where it gets complicated. While psychiatrists have full prescribing authority everywhere, psychiatric nurse practitioners (PMHNPs) operate under a patchwork of state laws that determine whether they can prescribe independently or need physician oversight.

As of 2025, about 34 states grant full practice authority (FPA) to nurse practitioners, meaning PMHNPs can evaluate, diagnose, and prescribe medications—including controlled substances—without a physician collaborator. But the other 16+ states still require some form of physician collaboration or supervision.

The Three Categories of NP Practice

1. Full Practice Authority States (FPA)
PMHNPs can practice independently. They open their own practices, manage their own patient panels, prescribe controlled substances under their own DEA number, and don’t need a physician to co-sign charts or review cases.

Examples: Washington, Oregon, Arizona, Colorado, Minnesota, Alaska, Connecticut, Rhode Island, Vermont, Maine, New Hampshire, Massachusetts, Maryland, Montana, Idaho, Wyoming, Nebraska, Iowa, South Dakota, North Dakota, New Mexico, Nevada, Arkansas (as of 2023), Hawaii, and Michigan (as of 2025).

What this means: A PMHNP in Colorado can see a patient via telehealth, diagnose depression, and prescribe sertraline and lorazepam—no physician involved. They bill under their own NPI, though Medicare reimburses at 85% of physician rates.

2. Reduced Practice States (Transitional Independence)
PMHNPs start with a collaborative agreement but can eventually practice independently after meeting experience requirements. During the initial period, they need a physician collaborator; after hitting the threshold, they’re free to practice alone.

Examples:

• New York: Requires 3,600 hours (about 2 years) of supervised practice. After that, no written agreement needed—just an informal ‘collaborative relationship’ (meaning you have physicians you can consult, but no oversight).
• Illinois: Requires 4,000 hours of collaboration plus 250 hours of continuing education in pharmacology. After that, you apply for Full Practice Authority licensure.
• California: Transitioning via AB 890. As of 2023, experienced NPs (3+ years) can practice in group settings without direct supervision (103 NP certification). By January 2026, they can apply for full independence (104 NP certification). New graduates still need physician-supervised protocols for at least 3 years.

What this means: A newly graduated PMHNP in New York must work under a psychiatrist for two years, with a written practice agreement. After 3,600 hours, they can practice solo—open their own telehealth practice, prescribe independently, no chart reviews required.

3. Restricted Practice States (Permanent Supervision)
PMHNPs must maintain physician collaboration indefinitely. They cannot prescribe without a supervising or collaborating physician, and the physician must review charts, be available for consultation, and co-sign certain prescriptions.

Examples:

• Texas: Requires a Prescriptive Authority Agreement with a physician for any prescribing. The NP cannot prescribe controlled substances unless explicitly delegated in the agreement. Texas law limits each physician to supervising 7 NPs/PAs at once. Monthly meetings required for the first 3 years, then quarterly. Important: Texas NPs generally cannot prescribe Schedule II controlled substances in outpatient settings except in very limited circumstances (e.g., terminal illness, hospice). This means most Texas PMHNPs don’t prescribe Adderall—they refer those cases to psychiatrists or work in clinics where the psychiatrist writes the initial script.

• Florida: NPs can apply for ‘autonomous practice’ only in primary care (family medicine, internal medicine, pediatrics). Psychiatric NPs are excluded from this independence. A PMHNP in Florida must practice under a physician’s supervision and follow written protocols. However, Florida law carves out an exception for ‘psychiatric nurses’ (defined as PMHNPs with 2+ years of experience under a psychiatrist): they can prescribe psychotropic controlled substances for mental health treatment without the 7-day Schedule II limit that applies to other NPs. Still, they need a psychiatrist collaborator by law.

• Pennsylvania: Requires a collaborative agreement for all NPs, regardless of experience. The agreement must specify the NP’s scope, including which drugs they can prescribe. PA NPs can prescribe Schedule II-V if delegated, but Schedule II prescriptions are limited to 30-day supplies, and the physician must be notified within 24 hours. The physician must review a portion of the NP’s charts regularly (often 10% every 3 months). No pathway to independence as of 2026, though legislation has been introduced.

What this means: A PMHNP in Texas who wants to manage ADHD patients via telehealth faces significant hurdles. They need to find a psychiatrist willing to collaborate (often for a fee—$1,000-$3,000/month is common), maintain monthly or quarterly meetings, and likely cannot prescribe stimulants at all. Many Texas PMHNPs work for clinics or telehealth companies that provide the supervising physician as part of the infrastructure.

Key Differences: What This Means for Your Practice

If you’re a PMHNP in a full practice state, your authority mirrors a psychiatrist’s in most ways. You can:

• Conduct initial evaluations and prescribe medications independently
• Manage controlled substances (stimulants, benzodiazepines, buprenorphine) under your own DEA number
• Bill under your own NPI (though Medicare pays 85% of physician rates)
• Open your own solo practice or join platforms like Klarity without needing a physician partner

If you’re a PMHNP in a restricted state, you’re functionally operating as a physician extender:

• You must find and maintain a collaborative agreement with a physician (often a psychiatrist for credibility with patients and insurers)
• The physician may charge you for supervision (monthly fees or percentage of collections)
• You cannot prescribe certain medications without physician approval or co-signature
• Some states (like Texas) effectively prohibit you from prescribing Schedule II stimulants, limiting your ability to treat ADHD independently

For Psychiatrists: If you’re in a restricted state, you may be approached by PMHNPs seeking collaboration. This can be a revenue stream (charging a supervision fee) or a way to expand your practice capacity. Just know that collaborative agreements come with liability considerations—you’re legally responsible for reviewing their work and being available for consultation. In Texas, you’re capped at 7 NP/PA collaborations at once.

State-by-State Breakdown: California, Texas, Florida, New York, Pennsylvania, Illinois

California: Transitioning to Full Practice by 2026

Psychiatrists: Full independent prescribing. No restrictions on telehealth prescribing as long as you conduct a ‘good faith exam’ (video counts). Must enroll in CURES (California’s PMP) and check it before prescribing Schedule II-IV drugs.

PMHNPs:

• Current (2023-2025): New NPs must work under physician-supervised ‘standardized procedures’ for at least 3 years. After 3 years, they can apply for 103 NP certification, which allows practice in group settings without direct physician supervision (but still within organizations that employ physicians).
• Starting January 2026: Experienced NPs (3+ years as a 103 NP) can apply for 104 NP certification, granting full independent practice—solo practice, solo prescribing, no physician oversight.
• What this means: By 2026, California effectively becomes a full practice state for experienced PMHNPs. If you’re a new grad, plan on 3 years under supervision. If you’ve been practicing elsewhere, you may qualify for faster certification.

Telehealth: California has strong telehealth parity laws (AB 744 mandates equal reimbursement for private payers). Medicare and Medi-Cal pay the same for telehealth as in-person. No state restrictions on controlled substance teleprescribing beyond federal rules.

Workforce Context: California has 11+ million people in mental health shortage areas. High demand, especially in rural and Central Valley counties. Psychiatrist-to-population ratio is about 1:5,300 statewide, but much worse in inland regions.

Texas: Restricted Practice, High Demand

Psychiatrists: Full independent prescribing. Can prescribe via telehealth, including controlled substances for psychiatric treatment. Cannot prescribe Schedule II opioids for chronic pain via telehealth (in-person required). Must check Texas PMP before prescribing controlled substances.

PMHNPs:

• Restricted practice: All NPs must have a Prescriptive Authority Agreement with a Texas-licensed physician to prescribe any medication. No independent practice pathway.
• Schedule II limitation: Texas law generally prohibits NPs from prescribing Schedule II controlled substances in outpatient settings except for terminal illness, hospice, or very narrow exceptions (recently, a limited exception was added for pediatric ADHD stimulants, but implementation is complex). In practice, most Texas PMHNPs do not prescribe Adderall, Ritalin, or other Schedule II stimulants—they refer to psychiatrists or work in settings where the physician writes the initial prescription.
• Supervision requirements: Physician must meet with NP monthly for the first 3 years of the agreement, then quarterly thereafter. Physician can supervise up to 7 NPs/PAs total.

What this means: Texas is one of the hardest states for PMHNPs to practice independently. Many work for large telehealth companies or health systems that provide the supervising physician. If you’re a PMHNP considering Texas, factor in the cost and complexity of maintaining a collaborator.

Telehealth: Texas law allows telemedicine prescribing if the standard of care is met. No explicit telehealth parity mandate for private payers, but many insurers voluntarily cover tele-mental health. Medicare/Medicaid pay at parity.

Workforce Context: Texas has one of the worst psychiatrist shortages in the nation—about 1 psychiatrist per 8,500-9,000 residents, with 380 mental health professional shortage areas needing 614+ psychiatrists. High demand, but NP scope limits ability to fill gaps independently.

Florida: Psych NPs Excluded from Autonomy

Psychiatrists: Full independent prescribing. Florida explicitly allows teleprescribing of controlled substances for psychiatric treatment (Florida Statute 456.47)—you can start stimulants or anxiolytics via video for Florida patients. Cannot prescribe controlled substances via telehealth for chronic pain (in-person required).

PMHNPs:

• Restricted for psych specialty: Florida’s 2020 law (HB 607) created ‘Autonomous APRN’ status for nurse practitioners in primary care (family medicine, internal medicine, pediatrics), but psychiatric NPs were excluded. Bills have been introduced to extend autonomy to PMHNPs (HB 771 in 2024), but they haven’t passed as of 2025.
• Current requirements: PMHNPs must practice under a supervising physician and follow written protocols. To prescribe psychotropic controlled substances, they must be designated as a ‘psychiatric nurse’ (PMHNP with 2+ years experience under a psychiatrist) and have a psychiatrist collaborator.
• Schedule II exception: Florida generally limits NPs to 7-day supplies of Schedule II narcotics, but ‘psychiatric nurses’ prescribing for mental illness are exempt—they can prescribe 30-day supplies of stimulants or other Schedule II psych meds.

What this means: Florida PMHNPs have more prescribing flexibility than Texas (they can prescribe stimulants), but they still need physician oversight. If you’re a PMHNP in Florida, you must find a psychiatrist willing to collaborate—often for a fee.

Telehealth: Strong telehealth support. Florida law allows out-of-state physicians to register for telehealth practice, but out-of-state NPs cannot prescribe controlled substances to Florida patients under that registration (they’d need full Florida licensure).

Workforce Context: Florida has a severe shortage—1 psychiatrist per ~9,000 residents, with 7.8 million people in shortage areas. High demand, but regulatory barriers for NPs limit supply.

New York: Independence After 3,600 Hours

Psychiatrists: Full independent prescribing. New York finalized regulations in mid-2025 that align state controlled substance prescribing rules with federal DEA waivers—you can prescribe controlled substances via telehealth as long as federal law allows it.

PMHNPs:

• Transitional independence: New NPs must enter a written practice agreement with a physician and follow written protocols for the first 3,600 hours (about 2 years full-time). After reaching 3,600 hours, they file an attestation with the state and no longer need a written agreement.
• Post-independence: After 3,600 hours, PMHNPs practice under a ‘collaborative relationship’ (informal consultation ties) but no supervision, chart reviews, or co-signatures required. They can prescribe independently, including controlled substances.
• Key detail: New York does not require routine chart co-signing or specific meeting frequency even during the initial 3,600 hours—the agreement is more of a formality and safety net.

What this means: New York is effectively a full practice state for experienced PMHNPs. If you’re new, plan on 2 years under a collaborator (often a psychiatrist for credibility), then you’re free to practice solo.

Telehealth: Strong telehealth parity laws. All insurers must cover telehealth at equal rates for behavioral health. New York requires e-prescribing for all controlled substances (no paper scripts) and mandates checking the state PMP (I-STOP registry) before prescribing Schedule II-IV drugs.

Workforce Context: New York has a high concentration of psychiatrists in NYC (about 1:2,900 residents statewide), but upstate regions are severely underserved. About 197 mental health shortage areas need ~230 additional psychiatrists. Telehealth and expanded NP scope are filling gaps.

Pennsylvania: Collaboration Required, No Independence Pathway (Yet)

Psychiatrists: Full independent prescribing. No state restrictions on controlled substance teleprescribing beyond federal rules.

PMHNPs:

• Reduced practice: All NPs must maintain a collaborative agreement with a physician indefinitely. No pathway to independence as of 2026 (though legislation has been introduced).
• Prescribing authority: NPs can prescribe Schedule II-V controlled substances if the collaborating physician delegates it and it’s in the agreement. Schedule II prescriptions are limited to 30-day supplies, and the physician must be notified within 24 hours.
• Chart review: The physician must review a portion of the NP’s charts regularly (often 10% every 3 months, though the exact number varies by practice setting).

What this means: Pennsylvania PMHNPs operate under permanent supervision. You’ll need to find a collaborating physician (often a psychiatrist for psychiatric practice), maintain regular contact, and ensure the agreement specifies your prescriptive authority. Some PMHNPs work for health systems or telehealth companies that provide the collaborator.

Telehealth: Pennsylvania Medicaid and major private insurers cover telepsychiatry, but the state doesn’t yet have a comprehensive telehealth parity statute. Efforts ongoing.

Workforce Context: Pennsylvania is mid-ranked in provider density (1:4,586 residents), with rural central PA facing the worst shortages. About 65 psychiatrist vacancies to eliminate shortage areas.

Illinois: 4,000 Hours to Independence

Psychiatrists: Full independent prescribing. No state restrictions on controlled substance teleprescribing beyond federal rules.

PMHNPs:

• Transitional independence: NPs must complete 4,000 hours of clinical practice under a collaborative agreement (about 2 years full-time) plus 250 hours of continuing education in pharmacology. After that, they can apply for ‘Illinois Full Practice Authority’ APRN licensure.
• During collaboration: NP prescriptions must list the collaborating physician’s name as the delegating practitioner. The physician’s name appears on scripts to signal it’s under delegation.
• After FPA: PMHNPs can prescribe independently, including controlled substances. They apply for their own mid-level controlled substance registration. Illinois does limit FPA NPs from prescribing opioids for chronic pain management without physician consultation, but psychiatric prescribing is unrestricted.

What this means: Illinois offers a clear path to independence for PMHNPs—start under a psychiatrist for 2 years, then practice solo. The state has been issuing FPA licenses since about 2019.

Telehealth: Illinois enacted strong telehealth parity laws (SB 667 in 2021) requiring private insurers to reimburse telehealth at the same rate as in-person through at least 2027. Medicaid and commercial plans pay equally for tele-mental health.

Workforce Context: Illinois has ~291 practitioners needed to eliminate mental health shortages. High demand in rural Illinois and some urban underserved areas.

Unique feature: Illinois allows licensed clinical psychologists with specialized training to prescribe a limited formulary of mental health medications under a psychiatrist’s supervision—adding to prescriber capacity.

Medication Management Reimbursement: What You’ll Actually Get Paid

Let’s talk numbers. Psychiatry medication management is well-reimbursed compared to other mental health services, and telehealth has generally achieved payment parity with in-person care.

Common Billing Codes

Initial Evaluation: CPT 90792 (Psychiatric Diagnostic Evaluation with Medical Services)

• What it covers: 60-minute initial consult where you take history, diagnose, and prescribe
• Medicare 2026 rate: ~$173 national average
• Private insurance: Often $200-$250+ depending on region and payer

Follow-Up Medication Management: Standard E/M office visit codes

• 99213 (15-minute follow-up, moderate complexity): Medicare pays ~$95
• 99214 (25-minute follow-up or higher complexity): Medicare pays ~$136
• 99215 (40-minute follow-up, rarely used): Medicare pays ~$192

Add-On Psychotherapy: If you do therapy + med management in the same visit

• 90833 (30-minute add-on therapy): Adds ~$80 to E/M code
• 90838 (60-minute add-on therapy): Adds ~$135 to E/M code

Most pure med management visits are 15-20 minutes (99213 or 99214). You’re checking on medication efficacy, side effects, doing brief counseling on adherence, and adjusting doses. These visits bill the same whether they’re in-person or telehealth.

Medicare vs. Private Insurance

Medicare: National benchmark. As of 2026, Medicare pays psychiatrists full fee schedule amounts for telehealth behavioral health visits. You use place-of-service code 02 or modifier -95 to indicate telehealth.

PMHNPs: Medicare reimburses NPs at 85% of physician rates when billed under the NP’s own NPI. So a 99213 that pays a psychiatrist $95 pays an NP $81. If the NP’s service is billed ‘incident to’ a physician (in-office, under direct supervision), it can be paid at 100%—but ‘incident to’ doesn’t apply to telehealth because the physician isn’t in the same location.

Private Insurance: Most commercial payers pay equal to or above Medicare rates. In high-cost markets (NYC, SF, LA), a 99214 might pay $150-$200. Many insurers have voluntarily adopted telehealth parity for behavioral health—meaning they pay the same for a video visit as an office visit.

Telehealth Parity Laws: Over 43 states have private insurance telehealth coverage laws, and about half mandate payment parity for behavioral health. Examples:

• Illinois: SB 667 (2021) requires equal reimbursement through at least 2027
• California: AB 744 (2019) mandates payment parity for telehealth contracts after 2021
• New York: Updated in 2021 to ensure telehealth is reimbursed, with flexibility in rate negotiations (generally parity in practice)
• Texas: Has a coverage mandate but not explicit payment parity—however, most insurers voluntarily pay equal rates for tele-mental health

Medicaid: Typically lower per-visit rates than Medicare or commercial, but Medicaid often has higher patient volumes. For example, Florida Medicaid might pay $60-$80 for a 15-minute med check; California Medi-Cal historically paid about 75% of Medicare rates (though recent investments aimed to raise behavioral health reimbursement). Many state Medicaids (NY, PA, IL) reimburse telehealth at the same rate as face-to-face.

Audio-Only Telehealth: As of 2022, Medicare covers certain mental health services via audio-only phone (for patients who cannot use video) at the same rate as office visits. This flexibility has been extended through 2024. Some states (Massachusetts, Illinois) require private payers to cover audio-only mental health similarly.

Real-World Economics

Let’s put this in perspective. If you’re a psychiatrist doing telehealth med management:

Scenario 1 – Medicare Patient, 15-Minute Follow-Up:

• Code: 99213
• Medicare pays: $95
• Patient copay (20%): $19
• You collect: $95 per visit
• If you see 4 patients/hour: $380/hour gross revenue

Scenario 2 – Private Insurance, 20-Minute Follow-Up:

• Code: 99214
• Private payer: $150 (typical in many markets)
• Patient copay varies (often $30-$50)
• You collect: $150 per visit
• If you see 3 patients/hour: $450/hour gross revenue

Scenario 3 – Cash-Pay/Self-Pay:

• Many direct-to-consumer telepsychiatry platforms charge $100-$200 per med management visit
• No insurance billing overhead, no claims denials
• You keep 100% (minus platform fee if applicable)

Key Point: Psychiatry medication management is one of the few specialties where telehealth reimbursement truly matches in-person rates. This is by design—policymakers recognized that cutting telehealth rates would decimate access to mental health care, so they’ve maintained parity.

Collaborative Care Model (Bonus Revenue Stream)

If you’re working with primary care teams, the Collaborative Care Model (CoCM) offers new billing opportunities. Psychiatrists serve as consultants to PCPs managing behavioral health patients. Specific CPT codes pay monthly fees:

• 99492 (first month): ~$161
• 99493 (subsequent months): ~$130
• 99494 (additional time): varies

These are per-patient-per-month fees for ongoing psychiatric consultation and case review. Medicare and some state Medicaids (NY, WA) reimburse these codes. Platforms like Klarity may integrate CoCM models if they coordinate with primary care.

What This Means for Your Practice

If you’re joining a platform like Klarity:

• Insurance-based: You’ll be paid at contracted rates (Medicare ~$95-$136 per follow-up, private insurance often higher). The platform handles billing and credentialing.
• Self-pay: The platform may charge patients $100-$200 per visit and pay you a percentage (often 50-70% after platform fees for patient acquisition, scheduling, EHR, etc.).

If you’re building your own practice:

• In-network: You’ll need to credential with insurers (6-12 months), negotiate rates, and handle billing. Expect Medicare rates as a baseline; private payers may pay 100-150% of Medicare.
• Out-of-network or cash-pay: You set your own rates ($150-$300 per visit is common for psychiatrists). No insurance headaches, but you’re responsible for patient acquisition and marketing.

Patient Acquisition Cost Reality Check:
Do NOT believe claims that you can acquire psychiatric patients for ‘$30-50’ through DIY marketing. Reality:

• SEO: Takes 6-12 months of consistent investment ($2,000-$5,000/month for content, technical optimization, link building) before generating meaningful patient flow. Most solo providers don’t have the expertise or patience.
• Google Ads: Mental health keywords cost $15-40+ per click. Conversion rates are low (most clicks don’t book). Realistic cost per booked patient: $200-400+, and you’ll burn through thousands in ad spend testing and optimizing campaigns.
• Directory Listings (Psychology Today, Zocdoc): Monthly subscription fees ($30-$100) plus you compete with hundreds of providers on the same page. Zocdoc charges per booking ($35-$100+ per lead). Total monthly cost adds up fast, and lead quality varies.
• Total DIY Marketing Cost: Factor in agency/consultant fees, ad spend, staff time to handle and qualify leads, no-show rates from cold leads, and failed campaigns. All-in cost per acquired patient is typically $200-500+ when you account for everything.

Platform Model (Like Klarity):
Klarity uses a pay-per-appointment model—you pay a standard listing fee per new patient lead (similar to Zocdoc’s per-booking model, not a monthly subscription). Key value props:

• No upfront marketing spend or monthly fees – you only pay when a qualified patient books with you
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs for EHR, video, scheduling)
• Both insurance and cash-pay patient flow (diversifies revenue)
• You control your schedule – only pay when you see patients, guaranteed ROI vs. gambling on marketing channels

The Smart Economic Choice:
Instead of spending $3,000-$5,000/month on marketing with uncertain results (and 6-12 months before you see ROI), a platform that handles patient acquisition removes the risk entirely. You pay per appointment, so your revenue is predictable and your only cost is directly tied to patient volume. For most providers—especially those starting out or scaling—this is a safer, faster path to building a full practice than DIY marketing.

Collaborative Agreements: What They Actually Require (and Cost)

If you’re a PMHNP in a state that requires physician collaboration, understanding what’s actually in these agreements—and what they’ll cost you—is critical.

What’s Typically Required

1. Scope of Practice:
The agreement must define what you’re authorized to do. For psych NPs, this usually includes:

• Evaluating and diagnosing mental health conditions within your specialty
• Prescribing medications (specific classes must be listed: antidepressants, antipsychotics, mood stabilizers, anxiolytics, stimulants, etc.)
• Ordering labs and diagnostic tests
• Providing psychotherapy (if within your scope)

Some states (like Florida and Pennsylvania) require the collaborating physician to be in the same specialty—meaning a PMHNP needs a psychiatrist collaborator to prescribe psychotropic medications, not just any MD.

2. Physician Availability:
The agreement must state how quickly the physician will respond if you need consultation. Common requirements:

• Available by phone or text within 2-4 hours during business hours
• Backup coverage if the primary collaborator is unavailable
• Specify protocols for emergencies (suicidal patients, medication reactions)

3. Chart Review and Quality Assurance:
Most states require the physician to review a percentage of your charts regularly. Examples:

• South Carolina: 10% of charts monthly
• Tennessee: Regular chart audits plus periodic on-site visits
• Texas: Monthly face-to-face meetings for first 3 years, then quarterly; physician must review cases at these meetings

This isn’t just a formality—state boards can audit collaborative agreements, and if you’re not in compliance (e.g., no documentation of chart reviews), both you and the physician can face disciplinary action.

4. Prescription Limitations:
The physician can limit your prescribing more narrowly than state law allows. Common limitations:

• No Schedule II stimulants (some physicians won’t delegate ADHD meds due to liability concerns)
• No prescribing to minors (some agreements restrict NPs to adult patients only)
• No buprenorphine (some physicians won’t delegate opioid use disorder treatment)

In states like Texas and Florida, the agreement must explicitly state that you’re authorized to prescribe controlled substances—otherwise, you can’t

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship